Gyula Petrányi Doctoral School of Allergy and Clinical Immunology

1.

Csikos, C., Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T., Váradi, B., Sajtos, G. Z., Kapus, I., Szoboszlai, Z., Szikra, D. P., Tircsó, G., Krasznai, Z. T., Molnár, S., Garai, I., Trencsényi, G.: Enhanced Tumor-to-Background Contrast with [52Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.
Pharmaceuticals. 19 (3), 1-16, (article identifier: 517), 2026.

doi DEA WoS

Journal metrics:

Q1 Drug Discovery (2025)

Q2 Molecular Medicine (2025)

Q1 Pharmaceutical Science (2025)

2.

Bokor, Á., Fodor, M.: Surgical management of refractory full-thickness macular holes with emphasis on autologous retinal transplantation: a narrative review.
Regen. Med. Rep. 3 (1), 20-24, 2026.

doi DEA

3.

Bokor, Á., Fodor, M.: Surgical management of refractory full-thickness macular holes with emphasis on autologous retinal transplantation: a narrative review.
Regenerative Medicine Reports 3 (1), 20-24, 2026.

doi DEA

4.

Csikos, C., Varga, A., Molnár, S., Hascsi, Z., Bátyi, F., Garai, I., Krasznai, Z. T.: The role of PET/CT in preoperative decision-making for secondary cytoreduction in recurrent ovarian cancer.
BMC Cancer [Epub ahead of print], 2026.

doi DEA

Journal metrics:

Q2 Cancer Research (2025)

Q2 Genetics (2025)

Q2 Oncology (2025)

5.

Aradi, Z., Bói, B., Nagy, G., Antal-Szalmás, P., Mezei, K., Horváth, I. F., Szántó, A.: Additive Value of Rheumatoid Factor Isotypes in Sjögren's Syndrome Patients with Joint Complaints of Different Etiologies: Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?.
Int. J. Mol. Sci. 26 (10), 1-13, (article identifier: 4797), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

6.

Jenei, V., Muszka, Z., Stigelmayer, Á., Debreceni, Z., Bácsi, A., Türk-Mázló, A., Koncz, G.: Anthracycline Treatments and the Presence of Tumor Cells Synergistically Modify the Composition of Macrophage Subpopulations in the Co-Culture System.
Int. J. Mol. Sci. 26 (18), 1-14, (article identifier: 9202), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

7.

Szinay, D., Szabó, K., Molnár, H., Béldi, T., Bencs, V., Lőrincz, H., Harangi, M., Griger, Z., Nagy-Vincze, M.: Assessment of Efficacy and Safety of Lipid-Lowering Treatment and Its Importance in Risk Assessment and Prevention in a Hungarian Myositis Cohort.
J Clin Med. 14 (10), 1-18, (article identifier: 3404), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

8.

Kapitány, A., Soltész, L., Stercel, V., Szabó, L., Somogyi, O., Janka, E. A., Nagy, V., Póliska, S., Gáspár, K., Hendrik, Z., Töröcsik, D., Dajnoki, Z., Szegedi, A.: Chronological maturation of the skin immune barrier is topographically different.
Mucosal Immunol. 18 (3), 730-741, 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

D1 Immunology and Allergy

9.

Ogum, A., Barna, S., Szoboszlai, Z., Krizsán, Á. K., Renaud, J., Mitchell, T., Budai, Á., Ország, G., Csikos, C., Garai, I.: Coronary Flow Reserve Evaluation with a Novel Multi-pinhole Collimator on Triple-Na-I-detector SPECT/CT in Coronary Artery Disease: a Pilot Study.
EANM Innovation 1, S234, 2025.

doi DEA

10.

Kolozsvári, B. L., Surányi, É., Zakarné Aszalós, Z., Lénárt, V., Chaker, R., Vitályos, G., Fodor, M.: Decades of Night-Shift Work Induce Diurnal Disruption and Corneal Adaptations: Evidence from Pentacam Analysis.
Int. J. Environ. Res. Public Health. 22 (4), 1-12, (article identifier: 474), 2025.

doi DEA Scopus

Journal metrics:

Q2 Health, Toxicology and Mutagenesis

Q2 Pollution

Q1 Public Health, Environmental and Occupational Health

11.

Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T., Szoboszlai, Z., Csikos, C., Váradi, B., Trencsényi, G., Tircsó, G., Garai, I.: HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.
Pathol. Oncol. Res. 31, 1-12, (article identifier: 1611999), 2025.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

12.

Bunda, S., Kálmán-Szabó, I., Szikra, D. P., Fekete, A., Szűcs, D., Péli-Szabó, J., Trencsényi, G., Képes, Z., Kálmán, F. K.: In vivo Evaluation of Copper-61-Labeled Prostate-specific Membrane Antigen Targeting Novel Radiopharmaceutical: first Steps toward Clinical Implementation.
ACS Pharmacol. Transl. Sci. 8 (6), 1580-1590, 2025.

doi DEA

Journal metrics:

Q2 Pharmacology

Q2 Pharmacology (medical)

13.

Muszka, Z., Jenei, V., Mácsik, R., Mezhonova, E., Diyab, S., Csősz, R., Bácsi, A., Türk-Mázló, A., Koncz, G.: Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death.
Cell Death Dis. 16 (1), 1-19, (article identifier: 273), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Cancer Research

Q1 Cell Biology

D1 Cellular and Molecular Neuroscience

D1 Immunology

D1 Medicine (miscellaneous)

14.

Barkóczi, A., Képes, Z., Péli-Szabó, J., Dienes, R. A., Károlyi, P. K., Papp, T., Kálmán-Szabó, I., Sass, T., Opposits, G., Kertész, I., Hajdu, I., Trencsényi, G., Deák, Á.: Metastasis and angiogenesis: preclinical PET study on hepatocellular carcinoma (He/De) tumor models.
Eur. J. Pharm. Sci. 212, 1-11, (article identifier: 107211), 2025.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science

15.

Horváth, D., Pénzes, Z., Molnár, P., Rebenku, I., Vereb, G., Szántó, M., Muzsai, S., Szegedi, A., Dajnoki, Z., Pázmándi, K. L., Fekete, T., Bácsi, A., Szöllősi, A. G.: Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype.
Front. Immunol. 16, 1-14, (article identifier: 1593141), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

Q1 Immunology and Allergy

16.

Lendvai, A., Béke, G., Hollósi, E., Braun, N., Theek, C., Kállai, J., Lányi, Á., Becker, M., Völker, J. M., Schulze zur Wiesche, E., Bácsi, A., Bíró, T., Mihály, J.: N,N-Dimethylglycine Sodium Salt as a Multifaceted Skin Agent Targeting Skin Inflammation, Microvascular Biology, and Senescence-Driven Hair Loss.
J. Invest. Dermatol. 145 (11), e44, 2025.

doi DEA

17.

Lendvai, A., Béke, G., Hollósi, E., Völker, J. M., Schulze zur Wiesche, E., Kállai, J., Lányi, Á., Bácsi, A., Bíró, T., Mihály, J.: N,N-Dimethylglycine sodium salt exerts anti-aging effects in human dermal papilla senescence models in vitro.
Immunol. Szle. 17 (3), 35, 2025.

DEA

18.

Dienes, R. A., Komor, L. A., Péli-Szabó, J., Berzi, A., Emri, M., Szikra, D. P., Fekete, A., Opposits, G., Jószai, I., Kertész, I., Fenyvesi, F., Trencsényi, G., Hajdu, I., Képes, Z.: Preclinical evaluation of Manganese-52 labelled cyclodextrin: a prostaglandin E2 affine imaging probe.
Eur. J. Pharm. Sci. 215, 1-7, (article identifier: 107344), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

19.

Hajdu, I., Komor, L. A., Dienes, R. A., Péli-Szabó, J., Kertész, I., Képes, Z., Trencsényi, G.: Preclinical Study of 52Mn-labeled Beta-cyclodextrin for Melanoma Imaging.
In: International Conferences & Exhibition on Nanotechnologies, Organic Electronics & Nanomedicine: Booklet, Nanotexnology, Thessaloniki, P3-1, 2025.

DEA

20.

Perge, B., Papp, G., Bói, B., Markóth, C., Bidiga, L., Farmasi, N., Balla, J., Tarr, T.: Prognostic Factors of the Progression of Chronic Kidney Disease and the Development of End-Stage Renal Disease in Patients with Lupus Nephritis: a Retrospective Cohort Study.
J. Clin. Med. 14 (3), 1-18, (article identifier: 665), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

21.

Sass, T., Péli-Szabó, J., Dienes, R. A., Árkosy, P., Opposits, G., Jószai, I., Fekete, A., Fenyvesi, F., Hajdu, I., Trencsényi, G., Képes, Z.: Radiolabelled Cyclodextrins for the Positron Emission Tomography Imaging of Breast Cancer: Preclinical Perspectives.
CTS-Clin. Transl. Sci. 18 (10), 1-9, (article identifier: 70379), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

Q2 Neuroscience (miscellaneous)

D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

22.

Zakarné Aszalós, Z., Kolozsvári, B. L., Lénárt, V., Pásztor, D., Hassan, Z., Surányi, É., Chaker, R., Fodor, M.: Sleep deprivation and corneal chronobiology: reevaluating overnight corneal changes.
Sci. Rep. 15 (1), 1-12, (article identifier: 801), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Multidisciplinary

23.

Ngo, M. T., Nagy, T., Szoboszlai, Z., Csikos, C., Dénes, N., Furka, A., Trencsényi, G., Garai, I.: The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: a Preliminary Report.
In Vivo. 39 (1), 160-171, 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q4 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Pharmacology

24.

Ranjbar, Y., Árokszállási, T., Szinay, D., Nagy, E. B., Tarr, T., Nagy-Vincze, M.: The Way Back from Tetraplegia or, Rare Neurological Manifestations of Eosinophil Granulomatosis with Polyangiitis.
J Clin Med. 14 (16), 1-8, (article identifier: 5652), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

25.

Képes, Z., Péli-Szabó, J., Kálmán-Szabó, I., Sass, T., Esze, R., Opposits, G., Jószai, I., Szikra, D. P., Fenyvesi, F., Hajdu, I., Trencsényi, G.: 52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: a Proof-of-concept Preclinical Study.
In Vivo. 38 (6), 2591-2600, 2024.

doi DEA Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Pharmacology

Gyula Petrányi Doctoral School of Allergy and Clinical Immunology

Publication list